Provectus Joins the Launch of Anthropic’s Claude for Healthcare and Life Sciences

Author:
Provectus, AI-first systems integrator and solutions provider

San Francisco, CA; January 12, 2026 – Provectus, an AI-first systems integrator, today announced its participation as a launch partner for Anthropic’s expanded healthcare and life sciences offering, including Claude for Healthcare and enhanced capabilities within Claude for Life Sciences.

The launch introduces HIPAA-ready AI capabilities designed to support healthcare providers, payers, and life sciences organizations across clinical operations, research and development, and regulatory workflows. Built on Anthropic’s latest Claude Opus 4.5 model, the platform delivers improved accuracy and reduced hallucinations, addressing core requirements for high-stakes, regulated environments.

Claude for Healthcare enables organizations to streamline operationally intensive workflows, such as prior authorization, claims and appeals, care coordination, and medical coding. New secure connectors allow Claude to access authoritative medical and administrative data sources, including PubMed, ICD-10, and clinical coverage databases, to reduce time spent on manual data retrieval while improving consistency and compliance.

In parallel, the expanded capabilities of Claude for Life Sciences extend support beyond preclinical research into clinical trial operations and regulatory workflows. New integrations with platforms, such as Medidata, ClinicalTrials.gov, bioRxiv, and medRxiv help organizations accelerate protocol development, monitor trial performance, and prepare regulatory submissions with greater efficiency and traceability.

As a launch partner, Provectus supports healthcare and life sciences organizations in operationalizing Claude across real-world environments. This includes designing compliant AI architectures, integrating Claude with clinical, research, and data platforms, and embedding agent-based workflows and AI solutions into existing operating models.

“Healthcare and life sciences leaders are moving past experimentation,” says Stepan Pushkarev, CEO and Co-Founder of Provectus. “Anthropic’s expansion of Claude is highly aligned with Provectus’ strategy of delivering AI solutions to the life sciences industry, aimed at modernizing R&D, laboratory and manufacturing operations, genomics and clinical workflows, provider experience, and end-to-end patient journeys.”

Together, Anthropic and its partner ecosystem are setting a new standard for enterprise AI in healthcare and life sciences. As a launch partner, Provectus will focus on helping organizations adopt Claude across clinical, research, and regulatory workflows, helping them embed compliant, trustworthy AI into core operations to drive measurable value.

About Provectus

Provectus is an artificial intelligence consultancy and solutions provider, helping companies in Financial Services, Healthcare & Life Sciences, and Retail & CPG achieve their objectives through AI. Provectus is headquartered in San Francisco, California. For more information, visit provectus.com.

About Anthropic

Anthropic is an AI safety and research company that specializes in the development of advanced AI models and systems. It has gained industry recognition for its contributions to generative AI technology by producing reliable research and creating highly impactful Large Language Models. Anthropic is based in San Francisco, California. For more information, visit anthropic.com.